Home AWOL

The A·WOL Consortium consists of both academic and industrial partners funded by The Bill & Melinda Gates Foundation, whose aim is to develop new drugs against onchocerciasis (river blindness) and lymphatic filariasis (elephantiasis).

Latest

A trial volunteer taking the new drug. Photo by Kate Dodd News article First in human trial for new drug targeting LF and onchocerciasis starts in Liverpool From: LSTM First in human trial for new drug targeting LF and onchocerciasis starts in Liverpool A new drug developed by an LSTM led partnership, which targets the neglected tropical diseases lymphatic filariasis and onchocerciasis has begun its...
News article LSTM awarded new GHIT grant to fund next stage in anti-Wolbachia drug discovery From: LSTM LSTM awarded new GHIT grant to fund next stage in anti-Wolbachia drug discovery LSTM, together with colleagues at the Department of Chemistry of the University of Liverpool (UoL) and Japanese pharmaceutical company Eisai...
News article World NTD Day 2020 From: LSTM World NTD Day 2020 #BeatNTDs: For good. For all
News article LSTM to host high level Global Health research symposium as UK prepares to secure worldwide funding for the future of global vaccinations From: LSTM LSTM to host high level Global Health research symposium as UK prepares to secure worldwide funding for the future of global vaccinations
Over 100 scientists, doctors, along with representatives from industry, charities and government agencies to meet in Liverpool. ...
News article LSTM’s emeritus Professor David Molyneux receives Queen’s Honour From: LSTM LSTM’s emeritus Professor David Molyneux receives Queen’s Honour LSTM’s Emeritus Professor David Molyneux has been appointed as Companion to the Most Distinguished Order of Saint Michael and Saint George (CMG) in...
News article Research into tropical eye worm, Loa loa, yields new tests to rapidly assess safety of anti-filarial drugs From: LSTM Research into tropical eye worm, Loa loa, yields new tests to rapidly assess safety of anti-filarial drugs Researchers at the LSTM’s Centre for Drugs and Diagnostics (CDDR), and University of Buea, Cameroon, have developed new models of the tropical eye...
News article In Memoriam: Renowned parasitologist Professor Dr C.P. Ramachandran (1937 – 2019) From: LSTM In Memoriam: Renowned parasitologist Professor Dr C.P. Ramachandran (1937 – 2019) It is with great sadness that LSTM has learned of the passing of its alumnus and Mary Kingsley Medal recipient, Professor Dr Cherubala Pathayapurayil...
News article LSTM and UoL researchers design new anti-Wolbachia drug with potential to treat onchocerciasis and lymphatic filariasis From: LSTM LSTM and UoL researchers design new anti-Wolbachia drug with potential to treat onchocerciasis and lymphatic filariasis Researchers from LSTM and the University of Liverpool have successfully optimised a hit from a whole cell screening of a 10000-compound library to...
News article LSTM led partnership awarded £1.5 million for NTD drug development From: LSTM LSTM led partnership awarded £1.5 million for NTD drug development An LSTM led partnership has been awarded nearly £1.5 million from the Medical Research Council (MRC) for the pre-clinical development of a candidate...
Event LSTM Scientific Conference: The role of vector control in disease elimination From: LSTM LSTM Scientific Conference: The role of vector control in disease elimination LSTM has organised a scientific conference to mark the significant contribution to Global Health of Professor Janet Hemingway CBE FRS on the occasion...
Event 2018 British Society for Parasitology Autumn Symposium From: LSTM 2018 British Society for Parasitology Autumn Symposium The theme of the 2018 Autumn Symposium is Parasite Glycobiology. 
This exciting one-day symposium will bring together leading...
Event LSTM Graduation - Save the Date! From: LSTM LSTM Graduation - Save the Date! LSTM is proud to be holding its inaugural graduation ceremony on Thursday 6 December 2018 at the Royal Liver Building, Liverpool.

Twitter

@AWOL_Wolbachia
We are seeking a talented individual to undertake a pivotal role in the next phase of basic and translational resea… https://t.co/MabxBEcLFk
25 Oct 2019
@AWOL_Wolbachia
The A·WOL (https://t.co/jQOGpLQRVg) and the Filariasis Lab within LSTM is recruiting for a Post-Doctoral Research A… https://t.co/uMsTLweZRU
25 Oct 2019
@AWOL_Wolbachia
RT : 'Behind the paper' - #LSTM's blogs on about her recent paper on 'Potential novel fas… https://t.co/FSE5Yx2Hw8
16 Jan 2019
@AWOL_Wolbachia
RT : Nice start to the New Year, our paper is out in Nature Comms on the discovery of 5 novel fast acting macrofilaricid… https://t.co/gHpjlit2Ho
2 Jan 2019
@AWOL_Wolbachia
RT : Our new paper is out. Industrial-scale screening in collaboration with leads to discov… https://t.co/eiO77fkegl
2 Jan 2019
@AWOL_Wolbachia
RT : The wants nominations of scientists for the new £50 note. We suggest Sir Ronald Ross, first UK Nobel… https://t.co/1gpXqJrUiJ
3 Nov 2018
@AWOL_Wolbachia
RT : How about Sir Ronald Ross, the UK's 1st Nobel Prize laureate (1902, Medicine) for proving #malaria transmission to… https://t.co/zecF0DTt3w
3 Nov 2018
@AWOL_Wolbachia
RT : Loading.... We are preparing and travelling to attend . Watch this space for the discussions we are going… https://t.co/rVwit5LacQ
17 Aug 2018
@AWOL_Wolbachia
RT : presents on validation of an in vitro co culture system for Brugia malayi drug screening… https://t.co/h5ATykRCbi
10 Apr 2018
@AWOL_Wolbachia
RT : on #AWOL industrial scale high through put drug screening for novel macrofilaricides against… https://t.co/vLfQiLkAZE
10 Apr 2018
@AWOL_Wolbachia
RT : New paper in from and colleagues. Well done! #filariasis… https://t.co/9ZCD3WYHkC
27 Mar 2018
@AWOL_Wolbachia
AWOL 10 year celebration mentioned in new newsletter eTropical https://t.co/IovovjSNcA]
31 Jan 2018